摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(7S,9S)-7,8,9,10-tetrahydro-6,7,9,11-tetrahydroxy-9-(N-propylcarbamoyl)-5,12-naphthacenedione | 128496-45-7

中文名称
——
中文别名
——
英文名称
(7S,9S)-7,8,9,10-tetrahydro-6,7,9,11-tetrahydroxy-9-(N-propylcarbamoyl)-5,12-naphthacenedione
英文别名
(2S,4S)-2,4,5,12-tetrahydroxy-6,11-dioxo-N-propyl-3,4-dihydro-1H-tetracene-2-carboxamide
(7S,9S)-7,8,9,10-tetrahydro-6,7,9,11-tetrahydroxy-9-(N-propylcarbamoyl)-5,12-naphthacenedione化学式
CAS
128496-45-7
化学式
C22H21NO7
mdl
——
分子量
411.411
InChiKey
KPTDHLRRYULYGZ-XMHCIUCPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.11
  • 重原子数:
    30.0
  • 可旋转键数:
    3.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    144.16
  • 氢给体数:
    5.0
  • 氢受体数:
    7.0

反应信息

  • 作为反应物:
    描述:
    (7S,9S)-7,8,9,10-tetrahydro-6,7,9,11-tetrahydroxy-9-(N-propylcarbamoyl)-5,12-naphthacenedionesodium hydroxidesilver trifluoromethanesulfonate 作用下, 以 四氢呋喃甲醇乙醚 为溶剂, 反应 5.0h, 生成 (7S,9S)-7-<(3'-amino-2',3',6'-trideoxy-α-L-lyxohexopyranosyl)oxy>-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(N-propylcarbamoyl)-5,12-naphthacenedione
    参考文献:
    名称:
    Synthesis and antitumor activity of novel 4-demethoxyanthracyclines
    摘要:
    A versatile and efficient synthetic route to 4-demethoxyanthracyclinones has been utilized in the preparation of a number of aglycons having 9-alkyl, 9-(hydroxylalkyl), or 9-carbamoyl substituents. Silver trifluoromethanesulfonate catalyzed coupling of these aglycons with various daunosamine derivatives has yielded a series of novel anthracyclines which have been evaluated as antitumor agents. 9-Alkylanthracyclines 22, 23, 33, and 34 have higher efficacy vs L-1210 leukemia than the parent 4-demethoxydaunorubicin (21), or the natural anthracyclines daunorubicin (1) and doxorubicin (2). 9-(Hydroxyalkyl) derivatives have in most cases high efficacy but are slightly less potent than 21. 9-Methyl analogue 22 has higher efficacy vs P388 leukemia than other anthracyclines tested, while 9-(hydroxymethyl) derivative 37 retains similar efficacy to anthracyclines 1, 2, and 21 but is considerably more potent. The N-substituted 9-carbamoylanthracyclines are devoid of antitumor activity.
    DOI:
    10.1021/jm00171a010
  • 作为产物:
    参考文献:
    名称:
    Synthesis and antitumor activity of novel 4-demethoxyanthracyclines
    摘要:
    A versatile and efficient synthetic route to 4-demethoxyanthracyclinones has been utilized in the preparation of a number of aglycons having 9-alkyl, 9-(hydroxylalkyl), or 9-carbamoyl substituents. Silver trifluoromethanesulfonate catalyzed coupling of these aglycons with various daunosamine derivatives has yielded a series of novel anthracyclines which have been evaluated as antitumor agents. 9-Alkylanthracyclines 22, 23, 33, and 34 have higher efficacy vs L-1210 leukemia than the parent 4-demethoxydaunorubicin (21), or the natural anthracyclines daunorubicin (1) and doxorubicin (2). 9-(Hydroxyalkyl) derivatives have in most cases high efficacy but are slightly less potent than 21. 9-Methyl analogue 22 has higher efficacy vs P388 leukemia than other anthracyclines tested, while 9-(hydroxymethyl) derivative 37 retains similar efficacy to anthracyclines 1, 2, and 21 but is considerably more potent. The N-substituted 9-carbamoylanthracyclines are devoid of antitumor activity.
    DOI:
    10.1021/jm00171a010
点击查看最新优质反应信息

文献信息

  • ADAMS, NIGEL;BLAKE, COLIN;BROADHURST, MICHAEL J.;BUSHNELL, DAVID J.;HASSA+, J. MED. CHEM., 33,(1990) N, C. 2375-2379
    作者:ADAMS, NIGEL、BLAKE, COLIN、BROADHURST, MICHAEL J.、BUSHNELL, DAVID J.、HASSA+
    DOI:——
    日期:——
查看更多